Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 4, 2016
Impact of circulating resistance-associated mutations on HIV pre-exposure prophylaxis (PrEP) efficacy: Modeling from antiretroviral resistance cohort analysis (ARCA) national databaseRoberto Rossotti, Vanni Borghi, Anna Paola Callegaro, et al.
Open Forum Infectious Diseases|June 7, 2017
Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus InfectionGiovanni Guaraldi, Roberto Rossotti, Gabriella Verucchi, et al.
Sexually Transmitted Infections|September 2, 2025
Attitudes and prescribing practices on doxycycline postexposure prophylaxis (DoxyPEP) among Italian infectious diseases physicians: findings from a National SIMIT SurveyRoberto Rossotti, Angelo Roberto Raccagni, Federico D'Amico, et al.
International Journal of STD & AIDS|January 20, 2025
Increasing incidence of <i>Mycoplasma genitalium</i> is driven by people living with HIV and PrEP usersRoberto Rossotti, Alice Nava, Federico D'Amico, et al.
Therapeutic Drug Monitoring|July 24, 2020
A Comparison of Tenofovir Predose Concentrations in Generic Pre-exposure Prophylaxis Formulations: A Short CommunicationDario Cattaneo, Cristina Gervasoni, Pietro Vinti, et al.
Pathogens (Basel, Switzerland)|June 28, 2023
Detection of Asymptomatic Mpox Carriers among High-Ri Men Who Have Sex with Men: A Prospective AnalysisRoberto Rossotti, Daniele Calzavara, Massimo Cernuschi, et al.
AIDS and Behavior|March 25, 2024
Do we Still Need Eligibility Criteria to Recommend PrEP? Impact of National Prescribing Requirements on Retention in Care and Sexually Transmitted Infections AcquisitionRoberto Rossotti, Alessandro Tavelli, Daniele Calzavara, et al.
HIV Medicine|January 24, 2024
Durability of doravirine with dolutegravir dual regimen compared with other dolutegravir-based dual combinationsRoberto Rossotti, Federico D'Amico, Nicholas Brian Bana, et al.
Respiratory Medicine|November 13, 2020
Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapyAlessandro Torre, Stefano Aliberti, Paola Francesca Castellotti, et al.
The Journal of Antimicrobial Chemotherapy|September 11, 2019
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohortLucia Taramasso, Patrizia Lorenzini, Antonio Di Biagio, et al.
Pageof 6